Logo image of ALHEX.PA

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

EPA:ALHEX - Euronext Paris - Matif - FR0004159473 - Common Stock - Currency: EUR

30.6  +0.2 (+0.66%)

Fundamental Rating

4

ALHEX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 30 industry peers in the Household Durables industry. The financial health of ALHEX is average, but there are quite some concerns on its profitability. ALHEX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALHEX had positive earnings in the past year.
In the past year ALHEX had a positive cash flow from operations.
ALHEX had positive earnings in 4 of the past 5 years.
ALHEX had a positive operating cash flow in each of the past 5 years.
ALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFALHEX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

ALHEX has a Return On Assets of 2.48%. This is in the lower half of the industry: ALHEX underperforms 60.00% of its industry peers.
ALHEX has a Return On Equity (6.20%) which is comparable to the rest of the industry.
ALHEX's Return On Invested Capital of 6.12% is on the low side compared to the rest of the industry. ALHEX is outperformed by 63.33% of its industry peers.
ALHEX had an Average Return On Invested Capital over the past 3 years of 8.77%. This is significantly below the industry average of 15.82%.
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROIC 6.12%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ALHEX.PA Yearly ROA, ROE, ROICALHEX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 1.94%, ALHEX is doing worse than 66.67% of the companies in the same industry.
ALHEX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.79%, ALHEX is doing worse than 73.33% of the companies in the same industry.
ALHEX's Operating Margin has declined in the last couple of years.
ALHEX's Gross Margin of 19.40% is on the low side compared to the rest of the industry. ALHEX is outperformed by 90.00% of its industry peers.
ALHEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
ALHEX.PA Yearly Profit, Operating, Gross MarginsALHEX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

ALHEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALHEX has about the same amount of shares outstanding.
Compared to 1 year ago, ALHEX has an improved debt to assets ratio.
ALHEX.PA Yearly Shares OutstandingALHEX.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ALHEX.PA Yearly Total Debt VS Total AssetsALHEX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.51 indicates that ALHEX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.51, ALHEX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
ALHEX has a debt to FCF ratio of 9.35. This is a negative value and a sign of low solvency as ALHEX would need 9.35 years to pay back of all of its debts.
The Debt to FCF ratio of ALHEX (9.35) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.24 indicates that ALHEX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.24, ALHEX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Altman-Z 2.51
ROIC/WACC0.9
WACC6.83%
ALHEX.PA Yearly LT Debt VS Equity VS FCFALHEX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.30 indicates that ALHEX should not have too much problems paying its short term obligations.
ALHEX has a worse Current ratio (1.30) than 66.67% of its industry peers.
ALHEX has a Quick Ratio of 1.01. This is a normal value and indicates that ALHEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.01, ALHEX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.01
ALHEX.PA Yearly Current Assets VS Current LiabilitesALHEX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for ALHEX have decreased strongly by -56.88% in the last year.
ALHEX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.22% yearly.
The Revenue for ALHEX has decreased by -28.88% in the past year. This is quite bad
Measured over the past years, ALHEX shows a decrease in Revenue. The Revenue has been decreasing by -9.93% on average per year.
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%

3.2 Future

Based on estimates for the next years, ALHEX will show a very strong growth in Earnings Per Share. The EPS will grow by 35.07% on average per year.
ALHEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.02% yearly.
EPS Next Y21.22%
EPS Next 2Y35.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALHEX.PA Yearly Revenue VS EstimatesALHEX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
ALHEX.PA Yearly EPS VS EstimatesALHEX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.78, ALHEX is valued correctly.
ALHEX's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of ALHEX to the average of the S&P500 Index (27.45), we can say ALHEX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 11.96, the valuation of ALHEX can be described as very reasonable.
Based on the Price/Forward Earnings ratio, ALHEX is valued a bit more expensive than 66.67% of the companies in the same industry.
ALHEX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.78
Fwd PE 11.96
ALHEX.PA Price Earnings VS Forward Price EarningsALHEX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALHEX is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as ALHEX.
Industry RankSector Rank
P/FCF 24.39
EV/EBITDA 3.34
ALHEX.PA Per share dataALHEX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

ALHEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALHEX's earnings are expected to grow with 35.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y35.07%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

ALHEX has a Yearly Dividend Yield of 1.60%.
ALHEX's Dividend Yield is comparable with the industry average which is at 4.71.
ALHEX's Dividend Yield is slightly below the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 1.6%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALHEX.PA Yearly Dividends per shareALHEX.PA Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

DP0%
EPS Next 2Y35.07%
EPS Next 3YN/A
ALHEX.PA Yearly Income VS Free CF VS DividendALHEX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M

HEXAOM

EPA:ALHEX (7/3/2025, 7:00:00 PM)

30.6

+0.2 (+0.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-11 2025-08-11
Inst Owners13.9%
Inst Owner ChangeN/A
Ins Owners2.81%
Ins Owner ChangeN/A
Market Cap212.36M
Analysts86
Price Target37.49 (22.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.6%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 14.78
Fwd PE 11.96
P/S 0.29
P/FCF 24.39
P/OCF 13.95
P/B 0.93
P/tB 1.56
EV/EBITDA 3.34
EPS(TTM)2.07
EY6.76%
EPS(NY)2.56
Fwd EY8.36%
FCF(TTM)1.25
FCFY4.1%
OCF(TTM)2.19
OCFY7.17%
SpS104.97
BVpS32.84
TBVpS19.59
PEG (NY)0.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 6.2%
ROCE 7.89%
ROIC 6.12%
ROICexc 12.79%
ROICexgc 39.35%
OM 2.79%
PM (TTM) 1.94%
GM 19.4%
FCFM 1.2%
ROA(3y)1.03%
ROA(5y)1.76%
ROE(3y)1.4%
ROE(5y)4.65%
ROIC(3y)8.77%
ROIC(5y)8.58%
ROICexc(3y)19.44%
ROICexc(5y)18.53%
ROICexgc(3y)71.44%
ROICexgc(5y)100.96%
ROCE(3y)11.34%
ROCE(5y)10.99%
ROICexcg growth 3Y-17.24%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.08%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y-3.63%
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 9.35
Debt/EBITDA 1.55
Cap/Depr 43.08%
Cap/Sales 0.9%
Interest Coverage 250
Cash Conversion 42.9%
Profit Quality 61.63%
Current Ratio 1.3
Quick Ratio 1.01
Altman-Z 2.51
F-Score6
WACC6.83%
ROIC/WACC0.9
Cap/Depr(3y)33.88%
Cap/Depr(5y)34.44%
Cap/Sales(3y)0.94%
Cap/Sales(5y)0.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.88%
EPS 3Y-13.22%
EPS 5YN/A
EPS Q2Q%-80.33%
EPS Next Y21.22%
EPS Next 2Y35.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.88%
Revenue growth 3Y-9.93%
Revenue growth 5YN/A
Sales Q2Q%-34.05%
Revenue Next Year-11.32%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5Y3.02%
EBIT growth 1Y-41.69%
EBIT growth 3Y-15.33%
EBIT growth 5YN/A
EBIT Next Year75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.7%
FCF growth 3Y-29.75%
FCF growth 5YN/A
OCF growth 1Y-65.3%
OCF growth 3Y-21.91%
OCF growth 5YN/A